Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Recent research suggests that natto—a fermented soy product traditional in Japanese cuisine—may offer cognitive benefits for adults over 40, though scientists emphasize that human evidence remains limited at this stage. A landmark 2025 randomized controlled trial found that nattokinase supplementation improved visuospatial function in individuals with asymptomatic intracranial stenosis, marking the first human clinical trial to directly test natto’s effects on cognition. However, this represents just one study with 120 participants; the broader picture comes largely from animal research and emerging mechanistic studies that suggest natto’s compounds—particularly nattokinase and vitamin K2—may support brain health through multiple pathways, including improved blood flow and reduced arterial stiffness.
While headlines about natto and dementia prevention deserve attention, it’s important to understand what the science actually shows and what remains speculative. A large Japanese cohort study examining soy product intake in people over 40 found no clear association between natto consumption and protection against disabling dementia, suggesting that simply eating more natto won’t guarantee cognitive benefits. This gap between animal promise and human reality is typical in brain health research—what works in laboratory mice doesn’t always translate to older adults in everyday life. The emerging research is intriguing enough to warrant discussion with your healthcare provider, but not yet strong enough to recommend natto as a dementia prevention strategy on its own.
Table of Contents
- What Does the New Research Actually Show About Natto and Brain Function After 40?
- The Promise and Limitations of Nattokinase for Brain Blood Flow
- Age, Arterial Health, and Cognitive Reserve After 40
- Comparing Natto to Other Evidence-Based Brain Health Approaches
- Safety Concerns and Who Should Be Cautious
- How Nattokinase and Vitamin K2 Work in the Brain
- The Road Ahead for Natto and Cognitive Research
- Conclusion
What Does the New Research Actually Show About Natto and Brain Function After 40?
The most significant recent finding comes from a double-blind, placebo-controlled trial published in 2025 that tested nattokinase—natto’s primary enzyme—in 120 people with asymptomatic intracranial or carotid stenosis, meaning they had narrowing in blood vessels leading to the brain but hadn’t experienced a stroke. Participants who received 8,000 fibrinolytic units (FU) of nattokinase daily for six months showed measurable improvements in visuospatial function—the ability to understand spatial relationships, recognize patterns, and mentally rotate objects. This type of cognitive skill often declines with age and is associated with fall risk and independence in older adults. The trial’s strength lies in its rigorous design: neither participants nor researchers knew who received the supplement versus placebo, and cognitive testing was standardized across all participants.
However, this study measured a specific cognitive domain in a specific population—people with diagnosed stenosis—not general brain health in healthy older adults. This distinction matters because it means we don’t yet know whether nattokinase provides similar benefits for someone without arterial narrowing who’s concerned about general cognitive aging. A large Japanese cohort study that followed adults over 40 for years and examined their soy product intake—including natto—actually found inconclusive results: total soy consumption was not associated with protection against disabling dementia in either men or women. This doesn’t mean natto is harmful; rather, it suggests that eating natto occasionally as part of a normal diet hasn’t been shown to prevent dementia in epidemiological studies.
The Promise and Limitations of Nattokinase for Brain Blood Flow
The biological mechanism connecting natto to brain health involves its enzyme nattokinase, which helps break down fibrin—a protein involved in blood clotting—and improve circulation throughout the body, including to the brain. Recent 2025 research has specifically explored how vitamin K2, another compound abundant in natto, may work through a different mechanism: by helping prevent arterial calcification, the hardening of blood vessel walls that’s associated with cognitive decline in older adults. When arteries stiffen, blood flow to the brain decreases, depriving neurons of oxygen and nutrients. By theoretically reducing calcification, vitamin K2 could indirectly protect cognitive function—though this mechanism has been demonstrated primarily in laboratory and animal studies, not yet robustly in humans.
The critical limitation here is that most evidence of natto’s cognitive benefits comes from animal research. For example, mice given natto for 12 weeks showed improved spatial learning and memory, with activation of BDNF (brain-derived neurotrophic factor), a protein crucial for brain cell growth and survival. In stroke models, nattokinase promoted neurogenesis—the growth of new brain cells—in rats, leading to improved cognitive recovery. In Alzheimer’s disease models, nattokinase increased clearance of beta-amyloid, the toxic protein that accumulates in Alzheimer’s brains, and reduced amyloid plaques. These findings are genuinely promising, but animal brains respond to interventions differently than human brains, and the doses used in animal studies often don’t translate directly to safe or effective human doses.
Age, Arterial Health, and Cognitive Reserve After 40
The targeting of research toward people over 40 makes biological sense: this is when arterial changes begin to accelerate and cognitive decline becomes measurable in population studies, even though most people at this age have no obvious symptoms. Between ages 40 and 65, many people develop subclinical atherosclerosis—narrowing of blood vessels—without knowing it. This asymptomatic phase is exactly where the 2025 nattokinase trial focused, reasoning that people with stenosis but no stroke history represent a critical window for intervention. If improving blood flow can protect cognition before a stroke occurs, that’s meaningfully different from trying to recover cognition after brain damage has already happened.
For someone in their 40s or 50s with no diagnosed cardiovascular or cognitive problems, the evidence for natto supplementation as a preventive strategy is much thinner. Eating natto as a food—which provides a range of fermented soy compounds beyond just nattokinase—might be different from taking isolated nattokinase supplements, which are what the clinical trials tested. The fermentation process in natto creates bioactive compounds like isoflavones and nattokinase simultaneously, and whole foods often work differently in the body than isolated extracts. A person could eat natto as part of a broader healthy diet without expecting dramatic cognitive effects, while remaining aware that the science on supplementation specifically is still emerging.
Comparing Natto to Other Evidence-Based Brain Health Approaches
Currently, strategies with far stronger evidence for cognitive aging prevention include cardiovascular exercise, Mediterranean-style diets, cognitive engagement, sleep optimization, and social connection. These approaches have been tested in large randomized trials and epidemiological studies involving tens of thousands of participants, with consistent findings showing 20–30% reductions in cognitive decline or dementia risk. Natto and nattokinase, by contrast, have one human trial of 120 people and mostly animal evidence. This doesn’t mean natto is useless—it means it shouldn’t displace proven approaches in someone’s brain health strategy.
A realistic view treats natto as potentially interesting complementary information rather than a primary tool. For someone already eating a Mediterranean diet, exercising regularly, maintaining social connections, and managing cardiovascular health, adding natto might be a low-risk experiment. For someone not yet doing those foundational things, focusing there first would be far more evidence-based. The tradeoff is time and attention: brain health strategies that have decades of validation research might deserve priority over emerging ones with promising mechanisms but limited human data. That said, if someone already enjoys natto as a food and tolerates it well, there’s minimal downside to including it regularly while the research develops.
Safety Concerns and Who Should Be Cautious
Nattokinase supplements—distinct from eating natto as food—carry a potential interaction with blood-thinning medications including warfarin, aspirin, and clopidogrel. Because nattokinase has anticoagulant properties, combining it with these medications could theoretically increase bleeding risk, though clinical incidents are rare. Anyone taking anticoagulants should consult their doctor before starting nattokinase supplements; eating natto as food is generally considered lower risk, though even here caution is warranted. Additionally, some people experience gastrointestinal distress from fermented soy products, particularly those with histamine sensitivity, so tolerance varies.
The Japanese cohort study mentioned earlier found no dementia protection from soy products at the population level, which is a reminder that not every biologically plausible intervention works as hypothesized in humans. Genetics, diet quality overall, cardiovascular health, education, and cognitive engagement likely matter far more than any single food or supplement for dementia risk. Someone relying on natto as their primary dementia prevention strategy while neglecting exercise, staying cognitively inactive, or eating a poor diet would be making a strategic error. Natto is not a shortcut to brain health; at best, it’s one small piece of a much larger puzzle.
How Nattokinase and Vitamin K2 Work in the Brain
The 2025 research on vitamin K2 particularly highlights why natto’s combination of compounds might matter more than isolated nattokinase. Vitamin K2 activates osteocalcin and matrix Gla-protein, which help direct calcium toward bones and teeth and away from soft tissues like artery walls. Arterial calcification—calcium accumulation in blood vessel walls—is emerging as an independent risk factor for cognitive decline, separate from traditional heart disease risk. In older adults with cognitive impairment, researchers have found correlations between arterial calcification and poor memory and processing speed.
By helping prevent calcification, vitamin K2 could theoretically preserve brain blood flow and cognition, though this mechanism has been more robustly demonstrated in cardiovascular and bone research than in cognitive studies specifically. Natto is one of the richest dietary sources of vitamin K2, offering more per serving than aged cheeses or other fermented foods. The fermentation process itself generates nattokinase and also preserves and increases the bioavailability of the original soy’s compounds. This means natto as a whole food might have a different profile than nattokinase supplements alone. However, this also underscores the limitation: nearly all clinical research to date has tested nattokinase supplements rather than actual natto, so we’re extrapolating from supplements to the food, which isn’t always accurate.
The Road Ahead for Natto and Cognitive Research
As the 2025 data accumulates, expect more research on nattokinase’s cognitive effects, particularly in people with subclinical stenosis or mild cognitive impairment. The National Institute of Health and similar funding bodies are increasingly interested in blood flow mechanisms in cognitive aging, and nattokinase fits that theme. However, meaningful human trials take years and require large numbers of participants, so major new findings won’t arrive quickly.
For now, the research sits in that uncomfortable middle ground where the biology is plausible, animal data is encouraging, but human evidence remains sparse. Looking forward, the most useful research would compare natto intake with other dietary approaches to arterial health in cognitively normal older adults followed for years. It would also clarify whether eating natto as food produces the same effects as nattokinase supplements, and which populations might benefit most. In the meantime, the existence of one positive human trial is enough to keep natto on the radar for anyone interested in emerging brain health science, but not enough to recommend it as a primary intervention.
Conclusion
New research, particularly a 2025 randomized controlled trial, suggests that nattokinase—the primary active enzyme in natto—may improve certain aspects of cognitive function in people with asymptomatic arterial narrowing. The mechanism is plausible: nattokinase improves blood flow and vitamin K2 in natto may reduce arterial stiffening, both of which could protect brain health. However, human evidence remains limited to one clinical trial and one large cohort study that found inconclusive results, while most supporting data comes from animal research.
For adults over 40 concerned about brain health, natto is a low-risk food worth including as part of a broader healthy eating pattern—it’s nutrient-dense, well-tolerated by most people, and increasingly available. But it should complement, not replace, interventions with far stronger evidence like cardiovascular exercise, Mediterranean-style eating, cognitive engagement, sleep, and social connection. If you have cardiovascular disease, take blood-thinning medications, or are considering nattokinase supplements specifically, discuss it with your healthcare provider first. As research continues, natto’s role in cognitive aging may clarify; for now, it represents an intriguing frontier rather than a proven solution.
